Erratum: Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β (Mol. Biol. Cell (2013) 24 (3449-3459) DOI: 10.1091/mbc.E12-10-0776);Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β

Molecular Biology of the Cell

Volumn 24, Issue 21, 2013, Pages 3449-3459

  Parvani, Jenny G ^a   Galliher Beckley, Amy J ^b   Schiemann, Barbara J ^c   Schiemann, William P ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; BETA3 INTEGRIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST EPITHELIUM; BREAST METASTASIS; CANCER GROWTH; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MUS;

ANIMALS; ANTIGENS, CD29; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; INTEGRIN BETA3; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA; TUMOR BURDEN;

EID: 84887074851     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-10-0776     Document Type: Erratum

References (42)

1. Barkan D et al. (2008). Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68, 6241-6250.
2. Barkan D et al. (2010). Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res 70, 5706-5716.
3. Bei L, Lu Y, Bellis S.L., Zhou W., Horvath E, Eklund E.A. (2007). Identification of a HoxA10 activation domain necessary for transcription of the gene encoding b3 integrin during myeloid differentiation. J Biol Chem 282, 16846-16859. (Pubitemid 47093193)
4. Ben-Ze'ev A (1999). The dual role of cytoskeletal anchor proteins in cell adhesion and signal transduction. Ann NY Acad Sci 886, 37-47. (Pubitemid 30042420)
5. Bhowmick NA, Zent R, Ghiassi M., McDonnell M, Moses H.L. (2001). Integrin b1 signaling is necessary for transforming growth factor-b activation of p38MAPK and epithelial plasticity. J Biol Chem 276, 46707-46713.
6. Butcher DT, Alliston T, Weaver V.M. (2009). A tense situation: forcing tumour progression. Nat Rev Cancer 9, 108-122.
7. Czekay R.P., Loskutoff D.J. (2009). Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism. J Cell Physiol 220, 655-663.
8. Diaz-Gonzalez F., Forsyth J, Steiner B., Ginsberg M.H. (1996). Trans-dominant inhibition of integrin function. Mol Biol Cell 7, 1939-1951. (Pubitemid 26415001)
9. Dontu G, Abdallah WM, Foley J.M., Jackson KW, Clarke MF, Kawamura MJ, Wicha M.S. (2003). In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17, 1253-1270. (Pubitemid 36583168)
10. Egeblad M, Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2, 161-174. (Pubitemid 37328786)
11. Erler JT, Weaver V.M. (2009). Three-dimensional context regulation of metastasis. Clin Exp Metastasis 26, 35-49.
12. Galliher AJ, Schiemann W.P. (2006). b3 integrin and Src facilitate transforming growth factor-b mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res 8, R42.
13. Galliher AJ, Schiemann W.P. (2007). Src phosphorylates Tyr284 in TGF-b type II receptor and regulates TGF-b stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 67, 3752-3758. (Pubitemid 46762161)
14. Galliher-Beckley A.J., Schiemann W.P. (2008). Grb2 binding to Tyr284 in TbR-II is essential for mammary tumor growth and metastasis stimulated by TGF-b. Carcinogenesis 29, 244-251. (Pubitemid 351359662)
15. Hayashi H, Sano H, Seo S., Kume T. (2008). The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expression. J Biol Chem 283, 23791-23800.
16. Huck L, Pontier SM, Zuo D.M., Muller W.J. (2010). b1-Integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression. Proc Natl Acad Sci USA 107, 15559-15564.
17. Huttenlocher A, Horwitz A.R. (2011). Integrins in cell migration. Cold Spring Harb Perspect Biol 3, a005074.
18. Kalluri R (2009). EMT: when epithelial cells decide to become mesenchymallike cells. J Clin Invest 119, 1417-1419.
19. Keely PJ (2011). Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. J Mammary Gland Biol Neoplasia 16, 205-219.
20. Lahlou H, Muller W.J. (2011). b1-Integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer. Breast Cancer Res 13, 229.
21. Lopez JI, Mouw JK, Weaver V.M. (2008). Biomechanical regulation of cell orientation and fate. Oncogene 27, 6981-6993.
22. Maschler S, Wirl G, Spring H., Bredow DV, Sordat I, Beug H, Reichmann E. (2005). Tumor cell invasiveness correlates with changes in integrin expression and localization. Oncogene 24, 2032-2041. (Pubitemid 40516196)
23. Micalizzi DS, Farabaugh SM, Ford HL (2010). Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15, 117-134.
24. Mierke CT (2009). The role of vinculin in the regulation of the mechanical properties of cells. Cell Biochem Biophys 53, 115-126.
25. Miettinen PJ, Ebner R, Lopez A.R., Derynck R. (1994). TGF-b induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127, 2021-2036.
26. Mitchell K, Svenson KB, Longmate W.M., Gkirtzimanaki K., Sadej R, Wang X, Zhao J., Eliopoulos AG, Berditchevski F, Dipersio C.M. (2010). Suppression of integrin a3b1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells. Cancer Res 70, 6359-6367.
27. Moses H, Barcellos-Hoff MH (2011). TGF-b biology in mammary development and breast cancer. Cold Spring Harb Perspect Biol 3, a003277.
28. Nieto MA (2011). The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 27, 347-376.
29. Parvani JG, Taylor MA, Schiemann W.P. (2011). Noncanonical TGF-b signaling during mammary tumorigenesis. J Mammary Gland Biol Neoplasia 16, 127-146.
30. Paszek MJ et al. (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254. (Pubitemid 41317594)
31. Pechkovsky DV, Scaffidi AK, Hackett T.L., Ballard J., Shaheen F, Thompson PJ, Thannickal V.J., Knight D.A. (2008). Transforming growth factor b1 induces avb3 integrin expression in human lung fibroblasts via a b3 integrin-, c-Src-, and p38 MAPK-dependent pathway. J Biol Chem 283, 12898-12908.
32. Penheiter SG, Singh RD, Repellin C.E., Wilkes MC, Edens M, Howe PH, Pagano R.E., Leof E.B. (2010). Type II transforming growth factor-b receptor recycling is dependent upon the clathrin adaptor protein Dab2. Mol Biol Cell 21, 4009-4019.
33. Preissner KT (1991). Structure and biological role of vitronectin. Annu Rev Cell Biol 7, 275-310.
34. Shibue T, Weinberg R.A. (2009). Integrin b1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 106, 10290-10295.
35. Sieg DJ, Hauck CR, Ilic D, Klingbeil C.K., Schaefer E., Damsky CH, Schlaepfer D.D. (2000). FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2, 249-256.
36. Song X, Thalacker FW, Nilsen-Hamilton M (2012). Synergistic and multidimensional regulation of plasminogen activator inhibitor type 1 expression by transforming growth factor type b and epidermal growth factor. J Biol Chem 287, 12520-12528.
37. Taylor MA, Amin JD, Kirschmann D.A., Schiemann W.P. (2011). Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-b signaling in breast cancer cells. Neoplasia 13, 406-418.
38. Taylor MA, Parvani JG, Schiemann W.P. (2010). The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-b in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia 15, 169-190.
39. Tian M, Neil JR, Schiemann W.P. (2011). Transforming growth factor-b and the hallmarks of cancer. Cell Signal 23, 951-962.
40. Wendt MK, Schiemann W.P. (2009). Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-b signaling and metastasis. Breast Cancer Res 11, R68.
41. Wendt MK, Smith JA, Schiemann W.P. (2009). p130Cas is required for mammary tumor growth and transforming growth factor-b-mediated metastasis through regulation of Smad2/3 activity. J Biol Chem 284, 34145-34156.
42. Wendt MK, Taylor MA, Schiemann B.J., Schiemann W.P. (2011). Downregulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Mol Biol Cell 22, 2423-2435.